These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7714974)

  • 41. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
    Bechara A; Casabé A; Chéliz G; Romano S; Fredotovich N
    J Urol; 1996 Mar; 155(3):913-4. PubMed ID: 8583605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodynamic study on erection induced by intracavernous injection of prostaglandin E1].
    Watanabe H
    Nihon Hinyokika Gakkai Zasshi; 1990 May; 81(5):732-8. PubMed ID: 2376930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacotesting with high dose prostaglandin E1 in impotence.
    Nisén H; Cormio L
    Ann Chir Gynaecol Suppl; 1993; 206():63-8. PubMed ID: 8291873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracavernous self-injection therapy for the treatment of erectile dysfunction.
    Chiang HS; Wen TC; Wu CC; Chiang WH
    J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
    He L; Wen J; Jiang X; Chen H; Tang Y
    Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feline penile erection induced by transurethral administration of sodium nitroprusside.
    Bivalacqua TJ; Champion HC; Wang R; Kadowitz PJ; Doherty PC; Hellstrom WJ
    Urol Res; 1999 Dec; 27(6):432-6. PubMed ID: 10651131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
    Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
    Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind randomized crossover study comparing intracorporeal prostaglandin E1 with combination of prostaglandin E1 and lidocaine in the treatment of organic impotence.
    Kattan S
    Urology; 1995 Jun; 45(6):1032-6. PubMed ID: 7771004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prostaglandin E1 in the long-term treatment of erectile dysfunction].
    Vrabec J
    Bratisl Lek Listy; 1992 Oct; 93(10):545-6. PubMed ID: 1288824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction.
    Hirsch IH; Smith RL; Chancellor MB; Bagley DH; Carsello J; Staas WE
    Paraplegia; 1994 Oct; 32(10):661-4. PubMed ID: 7831071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the alleviative action of neurotropin for penile pain associated with intracavernous injection of prostaglandin E1 assessed using the visual analogue scale.
    Sato Y; Suzuki N; Adachi H; Hisasue S; Horita H; Tsukamoto T
    Int J Impot Res; 1998 Mar; 10(1):1-3. PubMed ID: 9542683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alkalization does not alleviate penile pain induced by intracavernous injection of prostaglandin E1.
    Godschalk M; Gheorghiu D; Katz PG; Mulligan T
    J Urol; 1996 Sep; 156(3):999-1000. PubMed ID: 8709384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intracavernous injection test by prostaglandin E1].
    Otani T
    Nihon Rinsho; 2002 Jun; 60 Suppl 6():173-7. PubMed ID: 12166133
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
    Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
    Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracavernous injections of prostaglandin E1 for erectile dysfunction: patient satisfaction and quality of sex life on long-term treatment.
    Alexandre B; Lemaire A; Desvaux P; Amar E
    J Sex Med; 2007 Mar; 4(2):426-31. PubMed ID: 17367438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combining intracavernous injection and external vacuum as treatment for erectile dysfunction.
    Chen J; Godschalk MF; Katz PG; Mulligan T
    J Urol; 1995 May; 153(5):1476-7. PubMed ID: 7714970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.